Iris Biotech

Iris Biotech is a long-established, privately-held specialty chemical company focused on the custom and catalog production of peptides and related biochemicals. It functions as a critical enabler for academic, biotech, and pharmaceutical R&D, particularly in the fields of small molecule and proteomics research. The company's business model is based on providing high-quality research tools and intermediates rather than developing its own therapeutic drugs. Its stability is derived from decades of operational experience and a diversified customer base across the life sciences industry.

Expertise in solid-phase and solution-phase peptide synthesis, custom biochemical manufacturing, and purification/analytical services for research and pharmaceutical intermediates.

Iris Biotech competes in a fragmented market with large players like Bachem and Merck and numerous smaller specialty suppliers. It differentiates through custom synthesis expertise, quality, and customer service rather than scale. Competition is based on technical capability, reliability, and the ability to synthesize complex and novel compounds.